Advances in Molecular Activity of Potential Drugs 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (15 January 2023) | Viewed by 28567
Special Issue Editors
Interests: fungi; yeast; cell lines; cell cycle; cellular response to stress (plants, prokaryotic, and eukaryotic organisms); environmental research; mitochondria; genomics; proteome; genetic adaptations to interactions in the environment
Special Issues, Collections and Topics in MDPI journals
Interests: beta-amino acids; aminodiols; heterocyclic chemistry; drug design and synthesis; chiral catalysts; terpenoids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
An aging population; the appearance of new cancers and viral, bacterial, or fungal diseases; and insufficiently effective methods of treating existing diseases make it necessary to discover new drugs and to refine those that are already in use. Investigations into new drugs include research on both newly synthesized, novel compounds and those isolated from plants or secreted by microorganisms. Discovering the full molecular mechanisms of drugs or potential drugs is extremely important in terms of improving the quality of treatment and predicting the side effects of long-term treatment. The many years that have been spent searching for the molecular activity of drugs make sense in the context of extending their application. It is also important to look for drugs that work synergistically. In research on the molecular activity of drugs and potential drugs, both model organisms and cell lines are applied, which help us to obtain many valuable results in a relatively short time.
We are thus putting together a Special Issue entitled Advances in Molecular Activity of Potential Drugs. We invite papers that are related to the broadly understood progress in the field of investigating new compounds, potential drugs, and drugs that are already used in therapies. We encourage you to submit works carried out on model organisms, cell lines, animals, and as part of clinical trials. Research showing new molecular activities of already-used drugs, as well as on compounds that are potential drugs, are welcome. It is also important in this field of research to search for synergisms to find compounds that, when used together, act strongly and more efficiently in the therapy. Review articles summarizing published research are also very valuable for drawing conclusions and searching for further methods of research.
We look forward to your contributions and thank you for them in advance.
Dr. Magdalena Cal
Prof. Dr. Zsolt Szakonyi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- potential drugs
- drugs
- molecular mechanism of action
- cell cycle
- stress response
- cell lines
- model organisms
- clinical tests
- diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.